Control of asthma under specialist care: Is it achieved?

Chest

Volumn 128, Issue 1, 2005, Pages 78-84

  Gaga, Mina ^a   Papageorgiou, Niki ^b   Zervas, Eleftherios ^a   Gioulekas, Dimitris ^c   Konstantopoulos, Stavros ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Asthma; Clinical characteristics; Control; Exacerbations; Medication; Symptoms

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG;

ADULT; ARTICLE; ASTHMA; DISEASE CONTROL; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG USE; EXPERIENCE; FEMALE; FOLLOW UP; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZATION; SOCIAL BEHAVIOR; SYMPTOM; TEACHING HOSPITAL;

EID: 22244444845     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.128.1.78     Document Type: Article

References (35)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute. NIH publication No. 02-3659; updated 2003
2. Lagerlov P, Veninga CCM, Muskova M, et al, on behalf of the Drug Education Project (DEP) Group. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Eur Respir J 2000; 15:25-29
3. Van der Molen T, Postma DS, Schreurs AJM, et al. Discriminative aspects of two genetic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res 1997; 6:353-361
4. de Marco R, Bugiani M, Cazzoletti L. et al. ISAYA study group. The control of asthma in Italy: a multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy 2003; 58:221-228
5. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the asthma Insight and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807
6. Osman LM, Calder C, Robertson R, et al. Symptoms, quality of life, and health service contact among young adults with mild asthma. Am J Respir Crit Care Med 2000; 161:498-503
7. Bateman ED, Bousquet J, Braunstein GL. Is overall asthma control being achieved? A hypothesis-generating study. Eur Respir J 2001; 17:589-595
8. Price D, Ryan D, Pearce L, et al. The AIR study; asthma in real life. Asthma J 1999; 4:74-78
9. Sekerel B, Saraclar Y, Ones U, et al. on behalf of the Turkish National Allergy and Clinical Immunology Society. Childhood asthma perception in Turkey under real-life environment (CAPTURE) study. Pediatr Allergy Immunol 2001; 12:266-273
10. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9:687-695
11. Georgatou N, Gaga M, Bitsakou H, et al. Guidelines for the management of asthma. Issues Pulm Med 1994; 1:1-17
12. Georgatou N, Gaga M. Gratziou Ch, et al. Global strategy for asthma management and prevention. Greek Edition NHLBI/ WHO Report Publication 95-3659; Athens, 1997
13. Gaga M. Ganas K, Zervas E, et al., eds. Global guidelines for asthma management. GINA 2002. Greek Edition. Issues in Pulmonary Medicine. Athens, 2003
14. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
15. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1979; 118(suppl):1S-120S
16. Burney PG, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7:954-960
17. Torren J, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. Chest 1993; 104:600-608
18. Papageorgiou N, Gaga M, Marossis C, et al. Prevalence of asthma and asthma-like symptoms in Athens, Greece. Respir Med 1997; 91:83-88
19. Vermeire P. Difference in asthma management around the world. Eur Respir Rev 1994; 4:279-281
20. Rickard KA, Stempel DA. Asthma survey demonstrates that the goals of the NHLBI have not been accomplished. J Allergy Clin Immunol 1999; 103:S171
21. Anarella J, Roohan P, Balistreri E, et al. A survey of Medicaid recipients with asthma: perceptions of self-management, access, and care. Chest 2004; 125:1359-1367
22. Harrison TW, Oborne J, Newton S, et al. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004; 363:271-275
23. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337:1405-1411
24. Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma, Curr Med Res Opin 2004; 20:1403-1418
25. Bateman ED, Boushey HA, Bousquet J, et al, for the GOAL Investigators Group, Can guideline-defined asthma control be achieved? Am J Respir Crit Care Med 2004; 170:836-844
26. Ind PW, Dal Negro R, Colman NC, et al. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma. Respir Med 2003; 97:555-562
27. Nelson HS, Chapman KR, Pyke SD, et al. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers. J Allergy Clin Immunol 2003; 112:29-36
28. 2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol 2000; 106:500-506
29. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998; 339:147-152
30. Salvi SS, Krishna MT, Sampson AP, et al. The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma, Chest 2001; 119:1533-1546
31. Gong H Jr., Linn WS, Terrell SL, et al. Anti-inflammatory and lung function effects of montelukast in asthmatic volunteers exposed to sulfur dioxide, Chest 2001; 119:402-408
32. Lee DKC, Jackson CM, Haggart K, et al. Repeated dosing effects of mediator antagonists in inhaled corticosteroid-treated atopic asthmatic patients. Chest 2004; 125:1372-1377
33. Johansson G, Stallberg B, Tornling G, et al. Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest 2004; 125:916-923
34. Cote J, Bowie DM, Robichaud P, et al. Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. Am J Respir Crit Care Med 2001; 163:1415-1419
35. Thomson O'Brien MA, Freemantle N, Oxman AD, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (database online). Issue 2, 2004